Osimertinib in pretreated T790M-positive advanced non–small-cell lung cancer: AURA study phase II extension component
JCH Yang, MJ Ahn, DW Kim… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Osimertinib is an irreversible epidermal growth factor receptor (EGFR) tyrosine
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFR m) and T790M …
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFR m) and T790M …
Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component
JCH Yang, MJ Ahn, DW Kim… - Journal of Clinical …, 2017 - researchoutput.ncku.edu.tw
Purpose Osimertinib is an irreversible epidermal growth factor receptor (EGFR) tyrosine
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component.
J Yang, M Ahn, D Kim, S Ramalingam, L Sequist, W Su… - 2017 - christie.openrepository.com
Purpose Osimertinib is an irreversible epidermal growth factor receptor (EGFR) tyrosine
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component
JCH Yang, MJ Ahn, DW Kim… - Journal of clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose Osimertinib is an irreversible epidermal growth factor receptor (EGFR) tyrosine
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component
JCH Yang, MJ Ahn, DW Kim, SS Ramalingam… - Journal of Clinical …, 2017 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Osimertinib is an irreversible epidermal
growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) selective for both EGFR-TKI …
growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) selective for both EGFR-TKI …
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component.
JC Yang, MJ Ahn, DW Kim… - Journal of Clinical …, 2017 - europepmc.org
Purpose Osimertinib is an irreversible epidermal growth factor receptor (EGFR) tyrosine
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component.
J Yang, M Ahn, D Kim, S Ramalingam… - JOURNAL OF …, 2017 - iris.unito.it
Purpose Osimertinib is an irreversible epidermal growth factor receptor (EGFR) tyrosine
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component
JCH Yang, MJ Ahn, DW Kim… - Journal of …, 2017 - mdanderson.elsevierpure.com
Purpose Osimertinib is an irreversible epidermal growth factor receptor (EGFR) tyrosine
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component
JC Yang, MJ Ahn, DW Kim… - Journal of Clinical …, 2017 - research.manchester.ac.uk
Purpose Osimertinib is an irreversible epidermal growth factor receptor (EGFR) tyrosine
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component
JCH Yang, MJ Ahn, DW Kim… - JOURNAL OF …, 2017 - scholarworks.bwise.kr
Purpose Osimertinib is an irreversible epidermal growth factor receptor (EGFR) tyrosine
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …
kinase inhibitor (TKI) selective for both EGFR-TKI sensitizing (EGFRm) and T790M …